MCNULTY JAMES A
SEC insider (Form 3/4/5 filer). CIK 0001275857. Chief Financial Officer at Inhibitor Therapeutics, Inc. (INTI) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Dec 2, 2024. Located in LOS ANGELES, CA.
Companies MCNULTY JAMES A has filed insider reports for
- Inhibitor Therapeutics, Inc. (INTI): Officer, Chief Financial Officer
- RENOVARO INC. (RENB): Director
MCNULTY JAMES A
CIK: 0001275857
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
